Canopy Growth (CGC) Cash from Discontinued Operations (2022 - 2024)
Canopy Growth's (CGC) quarterly Cash from Discontinued Operations came in at 297587.4 in Q1 2024, up 100.91% year-on-year from 148118.14 in Q2 2023, and down 47.99% quarter-over-quarter from 572203.18 in Q4 2023.
Canopy Growth (CGC) Cash from Discontinued Operations (2022 - 2024) Analysis & Trends
Canopy Growth has disclosed Cash from Discontinued Operations across 3 years of filings, most recently posting 297587.4 for Q1 2024.
- Cash from Discontinued Operations for Q1 2024 came in at 297587.4, up 100.91% year-over-year; the trailing twelve-month figure through Mar 2024 was 39876575.24 (changed N/A YoY), and the FY2024 annual result was 39724577.91, up 67.08% from the prior year.
- Cash from Discontinued Operations came in at 297587.4 for Q1 2024 at Canopy Growth, down from 572203.18 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 572203.18 in Q4 2023 to a low of 49240487.81 in Q4 2022.
- The 3-year median for Cash from Discontinued Operations is 20373182.91 (2023), against an average of 20290105.26.
- Across the five-year window, Cash from Discontinued Operations jumped 101.16% in 2023 and surged 100.91% in 2024, its largest moves.
- Canopy Growth's Cash from Discontinued Operations stood at 49240487.81 in 2022, then jumped by 101.16% to 572203.18 in 2023, then sank by 47.99% to 297587.4 in 2024.
- The last three Cash from Discontinued Operations figures came in at 297587.4 (Q1 2024), 572203.18 (Q4 2023), and 9142869.77 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 297,587.40 |
| Mar 31, 2024 | 297,587.40 |
| Dec 31, 2023 | 572,203.18 |
| Dec 31, 2023 | 572,203.18 |
| Sep 30, 2023 | -9.14 Mn |
| Sep 30, 2023 | -9.14 Mn |
| Jun 30, 2023 | -31.60 Mn |
| Jun 30, 2023 | -31.60 Mn |
| Mar 31, 2023 | -32.62 Mn |
| Mar 31, 2023 | -32.62 Mn |
| Dec 31, 2022 | -49.24 Mn |
| Dec 31, 2022 | -49.24 Mn |